The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Microsatellite Instability in Colorectal Cancer-the Stable Evidence
Open accessAbstract
Microsatellite instability (MSI) is the molecular fingerprint of a deficient mismatch repair system. Approximately 15% of colorectal cancers (CRC) display MSI owing either to epigenetic silencing of MLH1 or a germline mutation in one of the mismatch repair genes MLH1, MSH2, MSH6 or PMS2. Methods to detect MSI are well established and routinely incorporated into clinical practice. A clinical and molecular profile of MSI tumors has been described, leading to the concept of an MSI phenotype in CRC. Studies have confirmed that MSI tumors have a better prognosis than microsatellite stable CRC, but MSI cancers do not necessarily have the same response to the chemotherapeutic strategies used to treat microsatellite stable tumors. Specifically, stage II MSI tumors might not benefit from 5-fluorouracil-based adjuvant chemotherapy regimens. New data suggest possible advantages of irinotecan-based regimens, but these findings require further clarification. Characterization of the molecular basis of MSI in CRC is underway and initial results show that mutations in genes encoding kinases and candidate genes with microsatellite tracts are over-represented in MSI tumors. Transcriptome expression profiles of MSI tumors and systems biology approaches are providing the opportunity to develop targeted therapeutics for MSI CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tumors with MSI tend to have a better prognosis but respond differently to standard chemotherapeutic regimens [75].”
From Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer (2024) · cites this paper as [75]
In the citing paper
“Approximately 15% of CRC tumors are characterized by microsatellite instability (MSI) [75].”
From Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer (2024) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G. D., & Schaid, D. J. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,131
Systematic review and meta-analysis
Gillies, A. (2019) · CRC Press eBooks · doi:10.1201/9781315377315-19 · Cited by 2,876
Cited by
Sorted by citations
Items 701–800 of 1,000
Liquid Biopsy in Advanced Colorectal Cancer: Clinical Applications of Different Analytes
Delcuratolo, M. D., Modrego-Sánchez, A., Bungaro, M., Antón-Pascual, B., Terán, S., Dipace, V., Novello, S., García‐Carbonero, R., Passiglia, F., & Graválos-Castro, C. (2023) · Journal of Molecular Pathology · doi:10.3390/jmp4030013 · Cited by 3
van den Berg, M. C., Berg, H. F., Stokowy, T., Høivik, E. A., Woie, K., Engerud, H., Ojesina, A. I., Haldorsen, I. S., Trovik, J., Bertelsen, B. I., et al. (2024) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2024-005377 · Cited by 3
Hulst, L. A., Cappuyns, S., Peeters, F., Vulsteke, F., Herpe, F. V., Cutsem, E. V., & Dekervel, J. (2024) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2024.06.004 · Cited by 3
Li, D., Bao, X., Lei, S., Cao, W., Zeng, Z., & Chen, T. (2024) · Biology · doi:10.3390/biology13080633 · Cited by 3
Gao, L., Li, Y., Wang, H., Liu, J., Zhang, R., Shan, W., Zeng, L., Zhao, Q., Li, Y., & Liu, J. (2024) · Cancer Science · doi:10.1111/cas.16368 · Cited by 3
Facteurs pronostiques des cancers colorectaux localisés
Bibeau, F., Hazebroucq, J., Pierson, R., & Khellaf, L. (2013) · Côlon & Rectum · doi:10.1007/s11725-013-0469-3 · Cited by 3
Colorectal Cancer and the Preventive Effects of Food Components
Wada, S. (2012) · InTech eBooks · doi:10.5772/31433 · Cited by 3
Yang, M., & Yeatman, T. J. (2017) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2017.1362316 · Cited by 3
Advances in fundamental oncology: the year 2020 update
Имянитов, Е. Н. (2021) · Practical oncology · doi:10.31917/2201001 · Cited by 3
Colorectal cancer in the young – outcomes following surgical management?
Newton, L., Munro, T. N., Hamid, M., & Shabbir, J. (2021) · Annals of The Royal College of Surgeons of England · doi:10.1308/rcsann.2021.0049 · Cited by 3
Cancer Genetics and Genomics – Part 2
Brothwell, M., & Barnett, G. C. (2022) · Clinical Oncology · doi:10.1016/j.clon.2022.02.014 · Cited by 3
DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer
Li, Y., Liao, L., Kong, L.-H., Wu, J., Tang, J., Han, K., Hou, Z., Zhang, C., Zhou, C., Zhang, L., et al. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02930-8 · Cited by 3
Zhan, Y., Ni, K., Liu, Z., xin, R., Han, Q., Ping, H., Liu, Y., Zhao, X., Wang, W. “., Yan, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33153-8 · Cited by 3
Exploration into Plasma Hsa_circ_0052184 as a New Biomarker of Colorectal Cancer Prognosis
Zheng, E., & Xiao, D. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s413451 · Cited by 3
Feng, Y., Guo, K., Jin, H., Jiang, J., Wang, M., & Lin, S. (2024) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2024.2325404 · Cited by 3
Liu, S., Yu, Y., Xu, J., Wang, Y., & Li, D. (2024) · Cell Biology International · doi:10.1002/cbin.12191 · Cited by 3
Cai, Y., Chen, X., Cai, Y., Chen, X.-J., Han, M., Lin, D., Hong, X., Hu, H., Hu, J., Liu, W., et al. (2024) · Surgical Endoscopy · doi:10.1007/s00464-024-11426-1 · Cited by 3
Systematic screening for functional exon-skipping isoforms using the CRISPR-RfxCas13d system
Sun, Q., Ma, X., Ning, Q., Li, S., Wang, P., Tan, X., Jin, Q., Zheng, J., Li, Y., & Dong, D. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101351 · Cited by 3
Cancer quasispecies and stem-like adaptive aneuploidy
Napoletani, D., Signore, M., & Struppa, D. C. (2013) · F1000Research · doi:10.12688/f1000research.2-268.v1 · Cited by 3
Glioblastoma signature in the DNA of blood-derived cells
Jain, S., Mazaheri, B., Raviv, N., & Bruck, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256831 · Cited by 3
He, L., Yang, J. H., Zhang, B., Wang, Y., Wang, J., & Ye, Q. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154390 · Cited by 3
Promising Targets and Drugs in Development for Colorectal Cancer
Thompson, C., Leong, S., & Messersmith, W. A. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.05.013 · Cited by 3
Wang, D., Zhang, X., Zhang, Y., Wu, Y., Guan, X., Zhu, W., Wang, M., Qi, C., & Shen, B. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s180145 · Cited by 3
Cancer Classification from Healthy DNA using Machine Learning
Jain, S., Mazaheri, B., Raviv, N., & Bruck, J. (2019) · CaltechAUTHORS (California Institute of Technology) · Cited by 3
Approach to Familial Predisposition to Colorectal Cancer
Ballester, V., & Cruz-Correa, M. R. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.06.001 · Cited by 3
Mathews, N. S., Masih, D., Mittal, R., Perakath, B., Sakthi, D., Rebekah, G. J., Pai, R. B., & Pulimood, A. B. (2019) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_224_18 · Cited by 3
Cancer Classification from Healthy DNAPreprint
Jain, S., Mazaheri, B., Raviv, N., & Bruck, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/517839 · Cited by 3
Regulation Of Spindle Orientation By A Mitotic Actin Pathway In Chromosomally Unstable Cancer Cells
Schermuly, N. (2020) · doi:10.53846/goediss-8319 · Cited by 3
Neoadjuvant chemoradiotherapy up-regulates PD-L1 in radioresistant colorectal cancer
Bae, S. U., Lee, H. W., Park, J. Y., Seo, I., Cho, J.-M., Kim, J. Y., Lee, J. Y., Lee, Y. J., Baek, S. K., Kim, N. K., et al. (2024) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2024.100906 · Cited by 2
Germline Mutations in Renal Neoplasms and Their Clinicopathological Correlations
Chen, M., Liu, Y., Yang, X., Gu, Y., Dong, L., Xu, H., Zhou, L., & Yang, X. (2025) · International Journal of Surgical Pathology · doi:10.1177/10668969251318038 · Cited by 2
ATM is associated with the prognosis of colorectal cancer: a systematic review
Wu, P., & Wen, Z. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1470939 · Cited by 2
Pan-cancer analysis predicts MBOAT2 as a potential new ferroptosis related gene immune checkpoint
Xie, Y., Zhang, S., Wu, Y., Qi, Y., Qi, S., Chen, X., & Chen, B. (2025) · Discover Oncology · doi:10.1007/s12672-025-02078-1 · Cited by 2
Bady, E., Ebner, J., Mandelkow, T., Huang, Z., Neipp, M., Mofid, H., Lárusson, H., Daniels, T., Isbert, C. M., Coerper, S., et al. (2025) · Pathology · doi:10.1016/j.pathol.2025.05.008 · Cited by 2
Correlation between KAT6A and PD-L1 expression and role of KAT6A in colorectal cancer
Zhou, Z., Zhao, J.-P., Zheng, S.-C., & Wang, T.-T. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i9.105937 · Cited by 3
Research progress on sirtuin family genes in colorectal cancer
Liu, T., Wu, T., Luo, L., Li, W., & Zhang, M. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1570030 · Cited by 2
Magnetic nanomotor-enhanced DNA cascade reaction for imaging DNA repair-related enzyme activity
Bai, H., Wu, X. D., Zhao, Y., Hu, J., Wang, J., Ye, Z., Mao, C., Li, Y., Chen, K., Wang, Y., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.169735 · Cited by 2
A continuously coupled attention neural network for MSI status classification in whole slide images
Pan, Z., Li, X., & Liu, L. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.109102 · Cited by 2
Wang, Z., Chang, F., Wu, H., Yuan, X., Chen, Y., & Han, J. (2025) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2025.09.004 · Cited by 2
Lin, C., Luo, T., Wu, M. Y., Li, F., Nunes, L., Mezheyeuski, A., Hammarström, K., Isaksson, A., Ljuslinder, I., Uhlén, M., et al. (2025) · ESMO Gastrointestinal Oncology · doi:10.1016/j.esmogo.2025.100268 · Cited by 2
Wang, R., & Yan, Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1671115 · Cited by 2
Gupta, G., Sadeghipour, N., Bicer, F., Elliott, A., Hinton, A. C., Lou, E., Vanderwalde, A. M., Özlük, A. A., Khushman, M. M., Malla, M., et al. (2025) · Cancers · doi:10.3390/cancers17243944 · Cited by 2
Cozac-Szőke, A.-R., Cotoi, O. S., Mauer, U., Steinestel, K., & Arndt, A. (2026) · Cancers · doi:10.3390/cancers18040666 · Cited by 2
Ma, T., Zhang, W., Pan, Y., Long, G., Mi, X., Jiang, J., Bai, F., Zhang, H., Hu, T., Zeng, Z., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1730155 · Cited by 2
Nero, C., Salvatore, L., Duranti, S., Anderson, G., Mastrantoni, L., Karimi, M., Mantini, G., Minucci, A., Maneri, G., Giacò, L., et al. (2026) · Targeted Oncology · doi:10.1007/s11523-026-01197-1 · Cited by 2
Zhan, Q., Zhang, S.-W., Cao, B., Chen, L.-M., & Xie, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062689 · Cited by 2
Courcelles, M., Hardy, M., Durette, C., Lanoix, J., Minati, R., Laverdure, J., Vincent, K., Perreault, C., & Thibault, P. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101581 · Cited by 2
Molecular profiling in colorectal cancer: current state of play and future directions
Deb, S., & Fox, S. B. (2014) · Colorectal Cancer · doi:10.2217/crc.13.82 · Cited by 2
Pamplona, R. S., Santos, C., Grasselli, J., Mollevı́, D. G., Dienstmann, R., Paré, L., Sanjuán, X., Biondo, S., Capellá, G., Tabernero, J. M., et al. (2014) · Colorectal Cancer · doi:10.2217/crc.14.15 · Cited by 2
Typing, grading, and staging of cases of tumor
Bignold, L. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816920-9.00010-9 · Cited by 2
Microsatellite Instability in Endometrial Carcinoma.
Toor, S. S., Kinra, P., Kumar, A., & Hothi, O. (2020) · Annals of Pathology and Laboratory Medicine · doi:10.21276/apalm.2907 · Cited by 2
Xu, Y., Li, Y., Zhu, Z., Yang, J., Tan, Y., Wang, Y., & Xu, X. (2022) · International Journal of Colorectal Disease · doi:10.1007/s00384-022-04150-6 · Cited by 2
Kalyanasundaram, S., Lefol, Y., Gundersen, S., Rognes, T., Alsøe, L., Nilsen, H. L., Hovig, E. J., Sandve, G. K., & Domańska, D. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286330 · Cited by 2
Han, L., Zhang, Y., Li, L., Zhang, Q., Liu, Z., Li, L., Hu, J. Y., Shi, X., Xiao Hua, S. H. I., & Qian, X. (2023) · Cancer Management and Research · doi:10.2147/cmar.s417470 · Cited by 2
FOXD1 expression-based prognostic model for uveal melanoma
Luo, Y., Ni, R., Jin, X., Feng, P., Dai, C., Jiang, L., Chen, P., Yang, L., & Zhu, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21333 · Cited by 2
Molecular genetic characteristics of colorectal cancer
Джелялович, С. Б., Grickevich, O. Y., Lazarev, A. E., Golubinskaya, E. P., & Maksimova, P. E. (2023) · Malignant tumours · doi:10.18027/2224-5057-2023-13-4-78-83 · Cited by 2
Karjula, T., Elomaa, H., Väyrynen, S. A., Kuopio, T., Ahtiainen, M., Mustonen, O., Puro, I., Niskakangas, A., Mecklin, J., Böhm, J., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03646-0 · Cited by 2
Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review
Colombo, A., Cordio, S. S., & Porretto, C. M. (2024) · International Journal of Gastrointestinal Intervention · doi:10.18528/ijgii240030 · Cited by 2
Choi, J., Lee, J., & Lee, S. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae423 · Cited by 2
Yazıcı, H., Kayaci, A. E., Sahin, M. Z. C., Bayir, C., Yildiz, A., Cinal, E., Ergenç, M., & Uprak, T. K. (2024) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2024.101633 · Cited by 2
Expression Pattern of AIFM3, VGLL4, and WNT4 in Patients with Different Stages of Colorectal Cancer
Bevanda, D., Racetin, A., Kelam, N., Filipović, N., Bevanda, M., Dimlić, M. R., Budimir, J., Glibo, D. B., Bevanda, I., Ramljak, D., et al. (2025) · Cancers · doi:10.3390/cancers17020166 · Cited by 2
Iyer, K. A., Tenchov, R., Ivanov, J. M., & Zhou, Q. A. (2025) · ACS Omega · doi:10.1021/acsomega.5c00693 · Cited by 2
Personalized therapy in metastatic colorectal cancer: biomarker-driven use of biologics
Sullo, F. G., Gallio, C., Matteucci, L., Bittoni, A., Muratore, M., Esposito, L., Ceredi, B., Gallo, G., Ulivi, P., Rapposelli, I. G., et al. (2025) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2025.2556911 · Cited by 3
Meunier, K., Ferron, M., Calmel, C., Fléjou, J., Pocard, M. D., & Praz, F. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22472 · Cited by 2
Yan, C., Liu, S., Pan, X., Chen, G., Ge, W., Guan, W., Liu, S., Li, M., He, J., & Zhou, Z. (2019) · Clinical Radiology · doi:10.1016/j.crad.2019.07.004 · Cited by 2
Molecular genetic testing in colon cancer: clinical aspects
Martianov, A. S., Kuligina, E. S., Romanko, A. A., & Имянитов, Е. Н. (2022) · Almanac of Clinical Medicine · doi:10.18786/072-0505-2022-50-002 · Cited by 2
Cancer Genetics and Genomics – Part 1
Brothwell, M., & Barnett, G. C. (2022) · Clinical Oncology · doi:10.1016/j.clon.2022.02.013 · Cited by 2
A rare cause of intestinal obstruction in children: signet-ring cell adenocarcinoma of the colon
Erginel, B. (2023) · Turkish Journal of Trauma and Emergency Surgery · doi:10.14744/tjtes.2023.64257 · Cited by 2
Yu, J., Gong, Y., Huang, X., & Bao, Y. (2024) · PeerJ · doi:10.7717/peerj.18401 · Cited by 2
Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era
Maoz, A., Biller, L. H., Giannakis, M., Rubinson, D. A., Jayakrishnan, T., Horiguchi, M., Ukaegbu, C. I., Caruso, A., Syngal, S., & Yurgelun, M. B. B. (2025) · JCO Precision Oncology · doi:10.1200/po-25-00700 · Cited by 2
Gaston, D., & Giacomantonio, C. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396967-5.00015-3 · Cited by 2
Bozer, M., Aşik, F., Acar, M., Haltaş, H., Yenıdünya, S., Canbal, M., Topçu, V., Yiğitoğlu, M. R., Gündüz, M., Gündüz, E., et al. (2013) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1210-84 · Cited by 2
Effect of genomic instability and mutations on the signaling pathways in colon cancer cells
Cui, M. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e639 · Cited by 2
Alikhan, M. B., Al‐Kawaaz, M., Kaul, K. L., & Sabatini, L. M. (2019) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2019.07.012 · Cited by 2
Laycock, A., Kang, A., Ang, S., Texler, M., & Bentel, J. M. (2021) · Human Pathology · doi:10.1016/j.humpath.2021.09.004 · Cited by 2
Michaud, E. J. (2011) · JAAPA · doi:10.1097/01720610-201107000-00017 · Cited by 2
Immunotherapy for colorectal cancer
Radecka, B. S., Gełej, M., Kotyla, M., & Kubiatowski, T. (2023) · Oncology in Clinical Practice · doi:10.5603/ocp.2023.0027 · Cited by 2
Analysis of microsatellite instability (MSI) in pediatric gonadal and extra-gonadal germ cell tumors
Montella, M., Errico, M. E., Ronchi, A., Zannini, G., Donofrio, V., Savarese, G., Sirica, R., Esposito, F., Martino, M. D., Papparella, A., et al. (2023) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2023.01039 · Cited by 2
Puccini, A., Nardin, S., Trevisan, L., Lastraioli, S., Gismondi, V., Ricciotti, I., Damiani, A., Bregni, G., Murialdo, R., Pastorino, A., et al. (2024) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000870 · Cited by 2
Zou, H., Liu, C., Ruan, Y., Fang, L., Wu, T., Han, S., Dang, T., Meng, H., & Zhang, Y. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2328746 · Cited by 2
Liu, B., Yin, X., Cai, Z., Shen, C., Jiang, T., Han, Y., Yin, Y., & Zhang, B. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-084496 · Cited by 2
Teran, S., Cámara, M., & Sobrino, J. A. N. (2021) · Case Reports in Oncological Medicine · doi:10.1155/2021/8896254 · Cited by 2
A stress response that allows highly mutated eukaryotic cells to survive and proliferatePreprint
Zabinsky, R. A., Mares, J., She, R., Zeman, M. K., Silvers, T. R., & Jarosz, D. F. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/515460 · Cited by 2
Liu, L., Zhao, J., Guo, H., Jia, J., Shi, L., Ma, J., & Zhang, Z. (2024) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2023.0039 · Cited by 1
Kravchenko, A. Y., Semina, E. V., Kakotkin, V. V., & Агапов, М. А. (2024) · Koloproktologia · doi:10.33878/2073-7556-2024-23-2-184-193 · Cited by 1
Routine use of MSI testing in colorectal cancer using a proposed algorithm
Ringgaard, M. L., Steiniche, T., & Krag, S. R. P. (2024) · Apmis · doi:10.1111/apm.13442 · Cited by 1
Wirta, E., Elomaa, H., Mecklin, J., Seppälä, T. T., Hyöty, M. K., Böhm, J., Ahtiainen, M., & Väyrynen, J. P. (2025) · Cancer Medicine · doi:10.1002/cam4.70555 · Cited by 1
Mi, S., Liao, Y.-J., Kang, D., Tang, X., Chen, G., Pan, Z., Zhan, J., & Zhang, R.-X. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-16989-4 · Cited by 1
Pane, K., Zanfardino, M., Grimaldi, A., Leone, I., Nuzzo, S., Salvatore, M., & Franzese, M. (2025) · Cancer Medicine · doi:10.1002/cam4.70468 · Cited by 1
Zhao, K., Pang, W., Liu, X., Ni, K., Gao, W., Tan, Z., Xue, J. W., Liang, W., Wu, X., Zhang, X., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.70756 · Cited by 1
Sun, X., Li, R., Wang, S., Zhao, W., Liu, H., Gao, W., Chen, P., Li, D., & Dong, G. (2025) · Surgery · doi:10.1016/j.surg.2025.109890 · Cited by 1
Harnessing mismatch repair deficiency for therapeutic targeting in cancers
Yenidogan, I., Tabori, U. Y., & Das, A. (2025) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2025.2608031 · Cited by 2
Sun, Q., Sun, R., He, B., Meng, H., & Jin, J. (2026) · International Journal of Colorectal Disease · doi:10.1007/s00384-025-05067-6 · Cited by 1
Current Status of the Diagnosis and Treatment of Mismatch Repair Deficient Colorectal Cancer
Bastin, D. J., Djedovic, V., Hyde, A. J., Goodwin, R. A., Asmis, T. R., & Vickers, M. M. (2026) · Biomedicines · doi:10.3390/biomedicines14051032 · Cited by 1
Abu-Hashish, H., Morocho, B. S., Espat, N. J., Somasundar, P. S., & Kwon, S. (2026) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2026.103008 · Cited by 1
Presencia de inestabilidad microsatélite en pacientes colombianos con adenocarcinoma colorrectal
Rodríguez, O. G., Ayala, R. L. B., Polo, J. F., Velasquez, E., López-Correa, P., & Parra-Medina, R. S. (2021) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.686 · Cited by 1
Yermakov, L. M., Kwon, R., & Konnick, E. Q. (2025) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2025.02.005 · Cited by 1
Yang, C., Du, M., Liu, L., Sh, C., Hu, W., Yan, S., Li, M., Gao, X., Yang, S., Zheng, L., et al. (2026) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359251408596 · Cited by 1
Gao, J., Zhao, Y., Cheng, Z., Yang, J., Jiang, L., Xi, S., Shi, S., Tian, G., Zhao, H., Yang, J., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-05133-7 · Cited by 1
Zhou, D., Ran, B., Kong, L., Liu, Y., Xiao, L., Chen, X., Liu, W. T., Li, X., Zhang, J. H., Zhang, J., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1839684 · Cited by 1
Kong, D., Feng, L., Sun, Y. X., Zhang, H., Fan, J., An, Y., Zhu, Y., Zhu, Y., Zhang, Q., Xiang, R., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02858-3 · Cited by 1
Metadata
- Authors
- Vilar, E., & Gruber, S. B.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Gruber, Stephen B.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2010-02-09
- Volume
- 7
- Issue
- 3
- Pages
- 153-162
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- PMC
- PMC3427139
- OpenAlex
- W2050658928
- Cited by
- 1,063
- References
- 100
- Citations by year
- 2026: 57 · 2025: 100 · 2024: 116 · 2023: 114 · 2022: 99 · 2021: 81 · 2020: 75 · 2019: 65 · 2018: 66 · 2017: 46 · 2016: 34 · 2015: 47 · 2014: 44 · 2013: 44 · 2012: 28
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (5P30 CA 46592, 1R01CA81488, R01CA081488, P30CA046592)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- microsatellite instability, colorectal cancer, mismatch repair deficiency, prognosis, predictive biomarkers, irinotecan, kinase mutations, targeted therapy
- MeSH terms
- DNA Repair, Humans, Colorectal Neoplasms, Germ-Line Mutation, DNA Repair Enzymes, Microsatellite Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review